Up next

Autoplay

Frontline Treatment of Chronic Myelogenous Leukemia

1 Views • 06/27/23
Share
Embed
administrator
administrator
Subscribers
0

There are currently three agents approved for the frontline treatment of patients with Philadelphia chromosome-positive chronic myelogenous leukemia, making an upfront treatment decision difficult. To address this, panelist explore possible first-line options and nuances of selecting therapies.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mds-cml

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay